Stocks
Atara Biotherapeutics (ATRA) EBITDA margin US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA margin, % | ? | -1 628% | -349.6% | -3 103% | -58.7% | 41.7% | 30.9% | |
| Changes by years, y/y, % | +1 278pp | -2 753pp | +3 044pp | +100pp | ||||
Atara Biotherapeutics. EBITDA margin, %
Atara Biotherapeutics. EBITDA margin, changes, pp
Atara Biotherapeutics (ATRA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA margin, % | ? | -32.3% | 41.6% | 20.5% | -96.4% | -239.4% | 30.9% | |
| Changes by years, y/y, % | +1 333pp | +148pp | +78pp | -48pp | -207pp | |||
| Changes by quarters, q/q, % | +16pp | +74pp | -21pp | -117pp | -143pp | |||
